Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2009 (388 publications)

paginate
Rudnick SI, Adams GP. Affinity and avidity in antibody-based tumor targeting. Cancer Biother Radiopharm. 2009 Apr;24(2):155-61.   PMCID: PMC2902227
Gitelson E, Al-Saleem T, Smith MR. Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment. Clin Adv Hematol Oncol. 2009 Jan;7(1):68-70.
Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, Henske EP. The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene. 2009 Apr;28(13):1594-604.   PMCID: PMC2664853
Kadariya Y, Yin B, Tang BQ, Shinton SA, Quinlivan EP, Hua X, Klein-Szanto A, Al-Saleem TI, Bassing CH, Hardy RR, Kruger WD. Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase (MTAP) Die Prematurely of T-Cell Lymphoma. Cancer Research. 2009 Jul;69(14):5961-9.   PMCID: PMC2757012
Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che MX, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A. MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02. Journal of Clinical Oncology. 2009 Jul;27(19):3177-84.   PMCID: PMC2716939
Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM. The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02. Clinical Cancer Research. 2009 Sep;15(17):5478-84.   PMCID: PMC2763098
Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic Concordance of Sporadic Synchronous Bilateral Renal Masses. J Urol. 2009 Mar;181(3):1061-2.
Abramowitz MC, Li T, Morrow M, Sigurdson ER, Anderson P, Nicolaou N, Freedman G. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation. Am J Clin Oncol. 2009 Feb;32(1):30-3.
Anderson P, Konski A. Non-cervical gynecologic malignancies. In: Haffty BG, Wilson LD, editors. Handbook of radiation oncology : basic principles and clinical protocols. Sudbury, Mass.: Jones and Bartlett; 2009. p. 605-28.
Anderson PR, Freedman G, Nicolaou N, Sharma N, Li T, Topham N, Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates?. Int J Radiat Oncol Biol Phys. 2009 May;74(1):81-5.
Freedman GM, Anderson PR, Li T, Nicolaou N. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer. 2009 Mar;115(5):946-51.   PMCID: PMC2993502
Freedman GM, Anderson PR, Li TY, Nicolaou N. Locoregional Recurrence of Triple-negative Breast Cancer After Breast-conserving Surgery and Radiation. Cancer. 2009 Jan;115(5):946-51.
Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009 Jul;74(3):689-94.   PMCID: PMC2720600
Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opinion on Therapeutic Targets. 2009 Mar;13(3):339-62.   PMCID: PMC2670612
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Targeting EGFR resistance networks in head and neck cancer. Cell Signal. 2009 Aug;21(8):1255-68.   PMCID: PMC2770888
Guo YP, Kock K, Ritter CA, Chen ZS, Grube M, Jedlitschky G, Illmer T, Ayres M, Beck JF, Siegmund W, Ehninger G, Gandhi V, Kroemer HK, Kruh GD, Schaich M. Expression of ABCC-Type Nucleotide Exporters in Blasts of Adult Acute Myeloid Leukemia: Relation to Long-term Survival. Clinical Cancer Research. 2009 Mar;15(5):1762-9.
Min H, Manion FJ, Goralczyk E, Wong YN, Ross E, Beck JR. Integration of prostate cancer clinical data using an ontology. J Biomed Inform. 2009 Dec;42(6):1035-45.   PMCID: PMC2784120
Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR. Cost implications of new treatments for advanced colorectal cancer. Cancer. 2009 May 15;115(10):2081-91.   PMCID: PMC2875773
Catalucci D, Latronico MV, Ceci M, Rusconi F, Young HS, Gallo P, Santonastasi M, Bellacosa A, Brown JH, Condorelli G. At Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr(17). Journal of Biological Chemistry. 2009 Oct;284(41):28180-7.   PMCID: PMC2788869
Cortellino S, Wang C, Wang B, Bassi MR, Caretti E, Champeval D, Calmont A, Jarnik M, Burch J, Zaret KS, Larue L, Bellacosa A. Defective ciliogenesis, embryonic lethality and severe impairment of the Sonic Hedgehog pathway caused by inactivation of the mouse complex A intraflagellar transport gene Ift122/Wdr10, partially overlapping with the DNA repair gene Med1/Mbd4. Dev Biol. 2009 Jan;325(1):225-37.   PMCID: PMC2645042
Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin AK, Heslin MJ, Bellacosa A, Arnoletti P. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biology & Therapy. 2009 Jan;8(1):94-100.   PMCID: PMC2683899
Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. Journal of the American College of Surgeons. 2009 Aug;209(2):180-7; quiz 294-5.   PMCID: NIHMS144099
Bleicher RJ, Kloth DD, Robinson D, Axelrod P. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol. 2009 May;99(6):356-60.
Bleicher RJ, Morrow M. Reply. Journal of the American College of Surgeons. 2009 Dec;209(6):797-8.   PMCID: not NIH funded
Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB. Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2009 Sep;27(25):4116-23.   PMCID: PMC2734423
Borghaei H, Mehra R, Simon G. Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer. Future Oncol. 2009 Feb;5(1):19-22.   PMCID: Comment - no NIH
Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. Eur J Pharmacol. 2009 Dec 25;625(1-3):41-54.   PMCID: PMC2783916
Demetri GD, Casali PG, Blay JY, von Mehren M, Morgan JA, Bertulli R, Ray-Coquard I, Cassier P, Davey M, Borghaei H, Pink D, Debiec-Rychter M, Cheung W, Bailey SM, Veronese ML, Reichardt A, Fumagalli E, Reichardt P. A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors. Clinical Cancer Research. 2009 Sep;15(18):5910-6.   PMCID: PMC2861356
Faller BA, Robu VG, Borghaei H. Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non-Small-Cell Lung Cancer. Clinical lung cancer. 2009 Nov;10(6):438-40.   PMCID: not NIH funded
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, Gershoni-Yahalom O, Brient-Litzler E, Bedouelle H, Ho JW, Campbell KS, Rager-Zisman B, Despres P, Porgador A. NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells. Journal of Immunology. 2009 Aug;183(4):2610-21.   PMCID: PMC2768489
Martinez E, Tatum KL, Weber DM, Kuzla N, Pendley A, Campbell K, Ridge JA, Langer C, Miyamoto C, Schnoll RA. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer causes & control : CCC. 2009 Feb;20(1):97-104.   PMCID: PMC2628415
Purdy AK, Campbell KS. SHP-2 expression negatively regulates NK cell function. J Immunol. 2009 Dec;183(11):7234-43.   PMCID: PMC2783243
Purdy AK, Campbell KS. Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther. 2009 Dec;8(23):2211-20.   PMCID: PMC2825280
Hensley HH, Merkel CE, Chang WC, Devarajan K, Cooper HS, Clapper ML. Endoscopic imaging and size estimation of colorectal adenomas in the multiple intestinal neoplasia mouse. Gastrointestinal endoscopy. 2009 Mar;69(3 Suppl):742-9.   PMCID: PMC2821747
Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen XQ, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko YD, Heikkinen T, Aaltonen K, Aittomaki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu JJ, Peock S, Cook M, Platte R, Evans DG, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FB, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TA, Gille HJ, Blok MJ, Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Chenevix-Trench G. No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Research and Treatment. 2009 Sep;117(2):371-9.   PMCID: PMC2728174
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernstrom H, Askmalm MS, Arver B, Malmer B, Domchek SM, Nathanson KL, Brunet J, Cajal TR, Yannoukakos D, Hamann U, Hogervorst FB, Verhoef S, Garcia EB, Wijnen JT, van den Ouweland A, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Revillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benitez J. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer. 2009 Dec;101(12):2048-54.   PMCID: PMC2795432
Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH. Worldwide esophageal cancer collaboration. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2009 Jan;22(1):1-8.
Yang J, Ma C, Wang L, Chen LL, Li JS. Effect of collimator and couch angle change on breast IMRT dose distributions. Journal of Applied Clinical Medical Physics. 2009 Jan;10(4):55-63.
Zhou Y, Hopper-Borge E, Shen T, Huang XC, Shi Z, Kuang YH, Furukawa T, Akiyama S, Peng XX, Ashby CR, Chen X, Kruh GD, Chen ZS. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochemical pharmacology. 2009 Mar;77(6):993-1001.   PMCID: NIHMS 84766
Allen JD, Jaffer ZM, Park SJ, Burgin S, Hofmann C, Sells MA, Chen S, Derr-Yellin E, Michels EG, McDaniel A, Bessler WK, Ingram DA, Atkinson SJ, Travers JB, Chernoff J, Clapp DW. p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood. 2009 Mar;113(12):2695-705.
Arias-Romero LE, Saha S, Villamar-Cruz O, Yip SC, Ethier SP, Zhang ZY, Chernoff J. Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009 Jun;69(11):4582-8.   PMCID: PMC2692630
Flaiz C, Chernoff J, Ammoun S, Peterson JR, Hanemann CO. PAK kinase regulates Rac GTPase and is a potential target in human schwannomas. Experimental Neurology. 2009 Jul;218(1):137-44.   PMCID: PMC2760977
Radu M, Chernoff J. The DeMSTification of Mammalian Ste20 Kinases. Curr Biol. 2009 May 26;19(10):R421-5.
Van den Broeke C, Radu M, Deruelle M, Nauwynck H, Hofmann C, Jaffer ZM, Chernoff J, Favoreel HW. Alphaherpesvirus US3-mediated reorganization of the actin cytoskeleton is mediated by group A p21-activated kinases. Proceedings of the National Academy of Sciences of the United States of America. 2009 May;106(21):8707-12.   PMCID: PMC 2688975
Egleston BL, Meireles SI, Flieder DB, Clapper ML. Population-based trends in lung cancer incidence in women. Semin Oncol. 2009 Dec;36(6):506-15.   PMCID: PMC2846780
Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, Gonzalez FJ, Peters JM. Regulation of Peroxisome Proliferator-Activated Receptor-beta/delta by the APC/beta-CATENIN Pathway and Nonsteroidal Antiinflammatory Drugs. Molecular Carcinogenesis. 2009 Oct;48(10):942-52.   PMCID: PMC2790141
Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen L, Meropol NJ. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of Oncology. 2009 Jul;20(7):1223-9.   PMCID: Private funding
Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ. Circulating Tumor Cells: Evolving Evidence and Future Challenges. The oncologist. 2009 Jan;14(11):1070-82.   PMCID: not NIH funded
Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Ehya H, Young NA, Watson JC, Weinberg DS, Nguyen MT, Cohen SJ, Meropol NJ, Litwin S, Tokar JL, Yeung AT. Proteomic analyses of pancreatic cyst fluids. Pancreas. 2009 Mar;38(2):e33-42.   PMCID: PMC2681236
Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009 May;74(1):55-9.   PMCID: PMC2933375
Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26.
Sweed MR, Edmonson D, Cohen SJ. Tumors of the Esophagus, Gastroesophageal Junction, and Stomach. Semin Oncol Nurs. 2009 Feb;25(1):61-75.
Connolly DC. Animal models of ovarian cancer. Cancer Treat Res. 2009 Jan;149:353-91.
Connolly DC, Hensley HH. Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents. Curr Protoc Pharmacol. 2009 Jun;45:14 12 1-14 12 26.   PMCID: PMC2904083
Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA. NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development. Cancer Research. 2009 Sep;69(18):7198-206.   PMCID: PMC2768619
Quinn BA, Brake T, Hua X, Baxter-Jones K, Litwin S, Ellenson LH, Connolly DC. Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PLoS One. 2009 Jan;4(12):e8404.   PMCID: 2796165
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):778-831.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Castello-Cros R, Cukierman E. Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. Methods Mol Biol. 2009 Jan;522:275-305.   PMCID: PMC2670062
Castello-Cros R, Khan DR, Simons J, Valianou M, Cukierman E. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC cancer. 2009 Jan;9:94.   PMCID: 2669806
Apicella C, Peacock SJ, Andrews L, Tucker K, Daly MB, Hopper JL. Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk. British Journal of Cancer. 2009 Feb;100(4):583-9.   PMCID: PMC2653735
Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yaneeklov T. Breast Cancer Screening and Diagnosis. Journal of the National Comprehensive Cancer Network. 2009 Nov;7(10):1060-96.   PMCID: No NIH funding
Daly MB. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns. 2009 Feb;18(1):42-8.   PMCID: PMC2629810
Fang CY, Cherry C, Devarajan K, Li TY, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecologic Oncology. 2009 Mar;112(3):594-600.   PMCID: PMC2697574
Huo DZ, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. Journal of Clinical Oncology. 2009 Mar;27(8):1184-90.   PMCID: PMC2667822
Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research. 2009 Jan;11(5).   PMCID: PMC2790858
Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB, Breast Canc Family Registry; Breast Canc Family R. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Research and Treatment. 2009 Jul;116(2):379-86.   PMCID: PMC2775077
Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB, kConFab k. Modification of Ovarian Cancer Risk by BRCA1/2-interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers. Cancer Research. 2009 Jul;69(14):5801-10.   PMCID: PMC2751603
Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP. A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis. Cancer Research. 2009 Sep;69(18):7459-65.   PMCID: PMC2747041
Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer Genetic Risk Assessment and Referral Patterns in Primary Care. Genet Test Mol Biomarkers. 2009 Dec;13(6):735-41.   PMCID: PMC 2935840
Whittemore AS, Stearman B, Venne V, Halpern J, Felberg A, McGuire V, Daly M, Buys SS. No evidence of familial correlation in breast cancer metastasis. Breast Cancer Research and Treatment. 2009 Dec;118(3):575-81.   PMCID: PMC 2783315
Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw. 2009 Sep;7(8):883-94.   PMCID: not NIH funded
Denlinger CS, Blanchard R, Xu L, Bernaards C, Litwin S, Spittle C, Berg DJ, McLaughlin S, Redlinger M, Dorr A, Hambleton J, Holden S, Kearns A, Kenkare-Mitra S, Lum B, Meropol NJ, O'Dwyer PJ. Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):97-105.   PMCID: PMC2746259
Berkholz DS, Shapovalov MV, Dunbrack RL, Karplus PA. Conformation Dependence of Backbone Geometry in Proteins. Structure. 2009 Oct;17(10):1316-25.   PMCID: PMC 2810841
Krivov GG, Shapovalov MV, Dunbrack RL. Improved prediction of protein side-chain conformations with SCWRL4. Proteins-Structure Function and Bioinformatics. 2009 Dec;77(4):778-95.   PMCID: PMC2885146
Weitzner B, Meehan T, Xu QF, Dunbrack RL. An unusually small dimer interface is observed in all available crystal structures of cytosolic sulfotransferases. Proteins-Structure Function and Bioinformatics. 2009 May;75(2):289-95.   PMCID: PMC 2728805
Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology. 2009 Jul;20(7):1242-8.   PMCID: PMC2699385
Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical Activity among Lung Cancer Survivors: Changes across the Cancer Trajectory and Associations with Quality of Life. Cancer Epidemiology Biomarkers & Prevention. 2009 Feb;18(2):664-72.   PMCID: PMC2674013
Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Correlates of physical activity among lung cancer survivors. Psycho Oncology. 2009 Jan;18(4):395-404.   PMCID: PMC2778598
Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, Godwin AK, Brinton LA. Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. Journal of the National Cancer Institute. 2009 Nov 04;101(21):1501-9.   PMCID: PMC2773186
Egleston BL, Scharfstein DO, MacKenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 2009 Jun;65(2):497-504.   PMCID: PMC2700847
Egleston BL, Wong YN. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Statistics in medicine. 2009 May;28(10):1498-511.   PMCID: PMC2741403
Fang CY, Egleston BL, Brown KM, Lavigne JV, Stevens VJ, Barton BA, Chandler DW, Dorgan JF. Family cohesion moderates the relation between free testosterone and delinquent behaviors in adolescent boys and girls. J Adolesc Health. 2009 Jun;44(6):590-7.   PMCID: PMC2687526
Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, Raysor S, Hooker S, Torres JB, Ramike T, Mastalski K, Kim TY, Kittles R. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila Pa). 2009 Mar;2(3):244-50.   PMCID: PMC2652509
Kurland BF, Johnson LL, Egleston BL, Diehr PH. Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims. Stat Sci. 2009 Jan;24(2):211.   PMCID: PMC2812934
Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER Analysis. Journal of Urology. 2009 Jan;181(1):29-33.   PMCID: PMC2782573
Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis. Journal of Urology. 2009 Feb;181(2):506-11.   PMCID: PMC 2703466
Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of Cancer Surgery: Implications for Patient Access to Optimal Care. Journal of Clinical Oncology. 2009 Oct;27(28):4671-8.   PMCID: PMC 3039919
Weinberg DS, Miller S, Rodoletz M, Egleston B, Fleisher L, Buzaglo J, Keenan E, Marks J, Bieber E. Colorectal cancer knowledge is not associated with screening compliance or intention. J Cancer Educ. 2009 Jan;24(3):225-32.   PMCID: PMC2724589
Wong YN, Freedland S, Egleston B, Hudes G, Schwartz JS, Armstrong K. Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer. Journal of Clinical Oncology. 2009 Jan;27(1):100-5.   PMCID: PMC 2645095
Wong YN, Freedland SJ, Egleston B, Vapiwala N, Uzzo R, Armstrong K. The role of primary androgen deprivation therapy in localized prostate cancer. Eur Urol. 2009 Oct;56(4):609-16.   PMCID: PMC2791191
Wambi CO, Sanzari JK, Sayers CM, Nuth M, Zhou ZZ, Davis J, Finnberg N, Lewis-Wambi JS, Ware JH, El-Deiry WS, Kennedy AR. Protective Effects of Dietary Antioxidants on Proton Total-Body Irradiation-Mediated Hematopoietic Cell and Animal Survival. Radiation Research. 2009 Aug;172(2):175-86.   PMCID: PMC 2746923
Aquino JB, Lallemend F, Marmigere F, Adameyko, Golemis EA, Ernfors P. The retinoic acid inducible Cas-Family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics. Neuroscience. 2009 Sep;162(4):1106-19.   PMCID: PMC2653735
Golemis EA, Serebriiskii I, Finley RL, Kolonin MG, Gyuris J, Brent R. Interaction trap/two-hybrid system to identify interacting proteins. Curr Protoc Protein Sci. 2009 Aug;Chapter 19:Unit 192.   PMCID: not NIH funded
Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural History, Growth Kinetics, and Outcomes of Untreated Clinically Localized Renal Tumors Under Active Surveillance. Cancer. 2009 Jul;115(13):2844-52.   PMCID: PMC2860784
Ignatoff JA, Chen YH, Greenberg RE, Pow-Sang JM, Messing EM, Wilding G. Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group. Urologic Oncology-Seminars and Original Investigations. 2009 Sep;27(5):496-501.   PMCID: PMC2743955
Forman AD, Hall MJ. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast J. 2009 Sep;15 Suppl 1:S56-62.   PMCID: not NIH funded
Gold HT, Hall MJ, Blinder V, Schackman BR. Cost Effectiveness of Pharmacogenetic Testing for Uridine Diphosphate Glucuronosyltransferase 1A1 Before Irinotecan Administration for Metastatic Colorectal Cancer. Cancer. 2009 Sep;115(17):3858-67.   PMCID: PMC2853177
Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW. BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian Cancer. Cancer. 2009 May;115(10):2222-33.
Amin RH, Cado D, Nolla H, Huang D, Shinton SA, Zhou Y, Hardy RR, Schlissel MS. Biallelic, ubiquitous transcription from the distal germline Ig kappa locus promoter during B cell development. Proceedings of the National Academy of Sciences of the United States of America. 2009 Jan;106(2):522-7.   PMCID: PMC2626736
Zhang HB, Rosenberg S, Coffey FJ, He YW, Manser T, Hardy RR, Zhang JK. A Role for cFLIP in B Cell Proliferation and Stress MAPK Regulation. Journal of Immunology. 2009 Jan;182(1):207-15.   PMCID: PMC 2720129
Florence WC, Xia CF, Gordy LE, Chen WL, Zhang YL, Scott-Browne J, Kinjo Y, Yu KO, Keshipeddy S, Pellicci DG, Patel O, Kjer-Nielsen L, McCluskey J, Godfrey DI, Rossjohn J, Richardson SK, Porcelli SA, Howell AR, Hayakawa K, Gapin L, Zajonc DM, Wang PG, Joyce S. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. Embo Journal. 2009 Nov;28(22):3579-90.   PMCID: PMC2782097
Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009 Nov;24 Suppl 2:S480-6.   PMCID: PMC2763168
Daniel LC, Heckman CJ, Kloss JD, Manne SL. Comparing alternative methods of measuring skin color and damage. Cancer Causes & Control. 2009 Apr;20(3):313-21.   PMCID: PMC2702995
Heckman CJ. Motivational Interviewing in Health Care: Helping Patients Change Behavior. Psycho-Oncology. 2009 Jan;18(1):110-1.
Heckman CJ, Wilson DB, Ingersoll KS. The influence of appearance, health, and future orientations on tanning behavior. American journal of health behavior. 2009 May;33(3):238-43.
Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS and Behavior. 2009 Jan;13(3):545-54.   PMCID: PMC2875059
Li JS, Jin L, Pollack A, Horwitz EM, Buyyounouski MK, Price RA, Ma CM. Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2009 Dec;75(5):1613-20.
Lawrence SH, Ramirez UD, Selwood T, Stith L, Jaffe EK. Allosteric inhibition of human porphobilinogen synthase. The Journal of biological chemistry. 2009 Dec 18;284(51):35807-17.   PMCID: 2791010
Lauritsen JP, Wong GW, Lee SY, Lefebvre JM, Ciofani M, Rhodes M, Kappes DJ, Zuniga-Pflucker JC, Wiest DL. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity. 2009 Oct 16;31(4):565-75.   PMCID: PMC2768560
Braunewell KH, Klein-Szanto A. Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+-sensor proteins (vol 335, pg 301, 2009). Cell and Tissue Research. 2009 May;336(2):345.   PMCID: PMC2742949
Cai KQ, Caslini C, Capo-chichi CD, Slater C, Smith ER, Wu H, Klein-Szanto AJ, Godwin AK, Xu XX. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS One. 2009 Jan;4(7):e6454.   PMCID: PMC2715102
Cai KQ, Wu H, Klein-Szanto AJ, Xu XX. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity. Gynecol Oncol. 2009 Jul;114(1):18-25.   PMCID: PMC2739736
Fu J, Zhang JR, Jin F, Patchefsky J, Braunewell KH, Klein-Szanto AJ. Promoter Regulation of the Visinin-like Subfamily of Neuronal Calcium Sensor Proteins by Nuclear Respiratory Factor-1. Journal of Biological Chemistry. 2009 Oct;284(40):27577-86.   PMCID: PMC2785686
Gumireddy K, Li AP, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D, Coukos G, Zhang L, Huang QH. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nature Cell Biology. 2009 Nov;11(11):1297-U69.   PMCID: PMC2784164
Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, Kruger WD. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 2009 Mar;23(3):883-93.   PMCID: PMC2653989
Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M, Klein-Szanto AJ, Schilder RJ, Ohmichi M, Testa JR, Kimura T. mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary. Clinical Cancer Research. 2009 Sep;15(17):5404-13.   PMCID: PMC2743856
Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen EE, Lingen MW, Martin L, Krishnaswamy S, Klein-Szanto A, Christensen JG, Vokes EE, Salgia R. The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research. 2009 Apr;69(7):3021-31.   PMCID: PMCID: PMC2871252
Makhov P, Golovine K, Uzzo RG, Wuestefeld T, Scoll BJ, Kolenko VM. Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells. Gene. 2009 Feb 15;431(1-2):39-46.   PMCID: PMC2741159
Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wang H, Gupta S, Kruger WD, Kraus JP, Shih DM. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. Faseb Journal. 2009 Jun;23(6):1721-7.   PMCID: PMC3221610
Singh LR, Kruger WD. Functional rescue of mutant human cystathionine beta-synthase by manipulation of Hsp26 and Hsp70 levels in Saccharomyces cerevisiae. The Journal of biological chemistry. 2009 Feb 13;284(7):4238-45.   PMCID: PMC2640983
Kunkle DA, Kutikov A, Uzzo RG. Management of Small Renal Masses. Seminars in Ultrasound Ct and Mri. 2009 Aug;30(4):352-8.
Kutikov A, Kunkle DA, Uzzo RG. Focal therapy for kidney cancer: a systematic review. Curr Opin Urol. 2009 Mar;19(2):148-53.   PMCID: PMC2779779
Kutikov A, Morgan TM, Resnick MJ. The impact of residency match information disseminated by a third-party website. J Surg Educ. 2009 Jul;66(4):212-5.
Kutikov A, Uzzo RG. The RENAL Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth. Journal of Urology. 2009 Sep;182(3):844-53.   PMCID: NIHMS151969
Lango MN. Multimodal treatment for head and neck cancer. Surg Clin North Am. 2009 Feb;89(1):43-52.
Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathological residual carcinoma and prognosis. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2009 Mar;31(3):328-37.
Lango MN, Myers JN, Garden AS. Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol. 2009 Jan;19(1):24-8.
Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu JS, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Biological Significance of Prolactin in Gynecologic Cancers. Cancer Research. 2009 Jun;69(12):5226-33.   PMCID: PMC2918393
Fan J, Paskalev K, Wang L, Jin L, Li J, Eldeeb A, Ma C. Determination of output factors for stereotactic radiosurgery beams. Medical Physics. 2009 Nov;36(11):5292-300.
Fourkal E, Veltchev I, Ma CM. Laser-to-proton energy transfer efficiency in laser-plasma interactions. Journal of Plasma Physics. 2009 Apr;75:235-50.
Hu W, Ding WJ, Yang HH, Shao MH, Wang BY, Wang JH, Wu SF, Wu SX, Jin LH, Ma CC. Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. Radiotherapy and Oncology. 2009 Dec;93(3):488-91.
Konski A, Movsas B, Konopka M, Ma C, Price R, Pollack A. Developing a radiation error scoring system to monitor quality control events in a radiation oncology department. Journal of the American College of Radiology : JACR. 2009 Jan;6(1):45-50.
Stathakis S, Roland T, Papanikolaou N, Li JS, Ma C. A Prediction Study on Radiation-induced Second Malignancies for IMRT Treatment Delivery. Technology in Cancer Research & Treatment. 2009 Apr;8(2):141-7.
Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CC, Feigenberg S. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: Evaluation of the impact on daily dose coverage. Radiother Oncol. 2009 Jun;91(3):314-24.
Zhu TC, Ahnesjo A, Lam KL, Li XA, Ma CM, Palta JR, Sharpe MB, Thomadsen B, Tailor RC. Report of AAPM Therapy Physics Committee Task Group 74: In-air output ratio, S-c, for megavoltage photon beams. Medical Physics. 2009 Nov;36(11):5261-91.
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK. Melanoma. Journal of the National Comprehensive Cancer Network. 2009 Mar;7(3):250-75.   PMCID: not NIH funded
Martin LP, Schilder RJ. Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol. 2009 Apr;36(2):112-25.   PMCID: NIHMS153585
Lewis NL, Lewis LD, Eder JP, Reddy NJ, Guo F, Pierce KJ, Olszanski AJ, Cohen RB. Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients With Advanced Cancers. Journal of Clinical Oncology. 2009 Nov;27(31):5262-9.   PMCID: PMC2773478
Bischoff K, Ballew AC, Simon MA, O'Reilly AM. Wing Defects in Drosophila xenicid Mutant Clones Are Caused by C-Terminal Deletion of Additional Sex Combs (Asx). PLoS One. 2009 Dec;4(12).   PMCID: PMC 2779589
Gauvin TJ, Fukui J, Peterson JR, Higgs HN. Isoform-Selective Chemical Inhibition of mDia-Mediated Actin Assembly. Biochemistry. 2009 Oct;48(40):9327-9.   PMCID: PMC2758331
Gollmer K, Asperti-Boursin F, Tanaka Y, Okkenhaug K, Vanhaesebroeck B, Peterson JR, Fukui Y, Donnadieu E, Stein JV. CCL21 mediates CD4(+) T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood. 2009 Jul;114(3):580-8.   PMCID: PMC2713469
Malyukova I, Murray KF, Zhu CR, Boedeker E, Kane A, Patterson K, Peterson JR, Donowitz M, Kovbasnjuk O. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2009 Jan;296(1):G78-G92.   PMCID: PMC2636932
Viaud J, Peterson JR. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther. 2009 Sep;8(9):2559-65.   PMCID: 2782767
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Young VA, Rall GF. Making It to the Synapse: Measles Virus Spread in and Among Neurons. Current Topics in Microbiology and Immunology. 2009 Jan;330:3-30.   PMCID: PMC 2794412
Rhodes J, Amsterdam A, Sanda T, Moreau LA, McKenna K, Heinrichs S, Ganem NJ, Ho KW, Neuberg DS, Johnston A, Ahn Y, Kutok JL, Hromas R, Wray J, Lee C, Murphy C, Radtke I, Downing JR, Fleming MD, MacConaill LE, Amatruda JF, Gutierrez A, Galinsky I, Stone RM, Ross EA, Pellman DS, Kanki JP, Look AT. Emi1 Maintains Genomic Integrity during Zebrafish Embryogenesis and Cooperates with p53 in Tumor Suppression. Molecular and Cellular Biology. 2009 Nov;29(21):5911-22.   PMCID: MC2772726
Koch WM, Ridge JA, Forastiere A, Manola J. Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma Results From Intergroup Study ECOG 4393/RTOG 9614. Archives of Otolaryngology-Head & Neck Surgery. 2009 Sep;135(9):851-8.   PMCID: PMC2846171
Poeta ML, Manola J, Goldenberg D, Forastiere A, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins. Clinical Cancer Research. 2009 Dec;15(24):7658-65.   PMCID: PMC2842212
Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, Garden AS, Kuettel MR, Sidhu K, Schultz CJ, Trotti A, Ang KK. Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024. Journal of Clinical Oncology. 2009 Oct;27(28):4727-32.   PMCID: PMC2754914
Belinsky MG, Skorobogatko YV, Rink L, Pei JM, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, von Mehren M, Testa JR, Godwin AK. High Density DNA Array Analysis Reveals Distinct Genomic Profiles in a Subset of Gastrointestinal Stromal Tumors. Genes Chromosomes & Cancer. 2009 Oct;48(10):886-96.   PMCID: PMC2830286
Ochs MF, Rink L, Tarn C, Mburu S, Taguchi T, Eisenberg B, Godwin AK. Detection of Treatment-Induced Changes in Signaling Pathways in Gastrointestinal Stromal Tumors Using Transcriptomic Data. Cancer Research. 2009 Dec;69(23):9125-32.   PMCID: PMC2789202
Rink L, Godwin AK. Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population. Current oncology reports. 2009 Jul;11(4):314-21.   PMCID: PMC2822338
Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 2009 Aug;8(8):2172-82.   PMCID: PMC2822341
Cheng H, Li J, Fazlieva R, Dai Z, Bu Z, Roder H. Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1. Structure. 2009 May 13;17(5):660-9.   PMCID: PMC2688836
Tzul FO, Kurchan E, Roder H, Bowler BE. Competition between Reversible Aggregation and Loop Formation in Denatured Iso-1-cytochrome c. Biochemistry. 2009 Jan;48(2):481-91.   PMCID: PMC 2645900
Roegiers F, Kavaler J, Tolwinski N, Chou YT, Duan H, Bejarano F, Zitserman D, Lai EC. Frequent unanticipated alleles of lethal giant larvae in Drosophila second chromosome stocks. Genetics. 2009 May;182(1):407-10.   PMCID: PMC2674838
Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol. 2009 Apr;113(1):21-7.   PMCID: PMC 2741166
Chen JQ, Brown TR, Russo J. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochimica Et Biophysica Acta-Molecular Cell Research. 2009 Jul;1793(7):1128-43.   PMCID: PMC2747085
Chen JQ, Russo J. ER alpha-negative and triple negative breast cancer: Molecular features and potential therapeutic approaches. Biochimica Et Biophysica Acta-Reviews on Cancer. 2009 Dec;1796(2):162-75.   PMCID: PMC2937358
Gutierrez PJ, Russo IH, Russo J. Cancer behaviour: an optimal control approach. International J Immunological Studies. 2009 Jan;1(1):31-65.   PMCID: NIHMS96790
Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA. Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats. Environmental Health Perspectives. 2009 Jun;117(6):910-5.   PMCID: PMC2702405
Kocdor H, Kocdor MA, Russo J, Snider KE, Vanegas JE, Russo IH, Fernandez SV. Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. Cell Biol Int. 2009 Nov;33(11):1135-43.   PMCID: PMC2783498
Mello ML, Russo P, Russo J, Vidal BC. Entropy of Feulgen-stained 17-beta-estradiol-transformed human breast epithelial cells as assessed by restriction enzymes and image analysis. Oncology reports. 2009 Jun;21(6):1483-7.   PMCID: not NIH funded
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor-Dependent, as Well as Independent, Genotoxic Effects. Steroid Enzymes and Cancer. 2009 Jan;1155:132-40.
Sohn JA, Litwin S, Seeger C. Mechanism for CCC DNA synthesis in hepadnaviruses. PLoS One. 2009 Jan;4(11):e8093.   PMCID: PMC2778999
Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, Seeger C. Focal distribution of hepatitis C virus RNA in infected livers. PLoS One. 2009 Jan;4(8):e6661.   PMCID: PMC2722721
Ma X, Serna A, Xu RH, Sigal LJ. The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation. J Immunol. 2009 Apr 15;182(8):4601-7.   PMCID: PMC2756161
Flint SJ, Enquist LW, Racaniello VR, Skalka AM, American Society for Microbiology. Principles of virology. Washington, DC: ASM Press; 2009.
Merkel G, Andrake MD, Ramcharan J, Skalka AM. Oligonucleotide-based assays for integrase activity. Methods. 2009 Apr;47(4):243-8.   PMCID: PMC2743288
Sykes SM, Stanek TJ, Frank A, Murphy ME, McMahon SB. Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53. Journal of Biological Chemistry. 2009 Jul;284(30):20197-205.   PMCID: PMC 2740446
Altomare DA, Menges CW, Pei J, Zhang L, Skele-Stump KL, Carbone M, Kane AB, Testa JR. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Proc Natl Acad Sci U S A. 2009 Mar 03;106(9):3420-5.   PMCID: PMC2644256
Capo-Chichi CD, Cai KQ, Testa JR, Godwin AK, Xu XX. Loss of GATA6 Leads to Nuclear Deformation and Aneuploidy in Ovarian Cancer. Molecular and Cellular Biology. 2009 Sep;29(17):4766-77.   PMCID: PMC2725711
Ivanov SV, Miller J, Lucito R, Tang CL, Ivanova AV, Pei JM, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI. Genomic events associated with progression of pleural malignant mesothelioma. International journal of cancer. 2009 Feb;124(3):589-99.   PMCID: PMC2933144
Menges CW, Altomare DA, Testa JR. FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis. Cell cycle (Georgetown, Tex). 2009 Aug 15;8(16):2528-34.   PMCID: PMC2739729
Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT. Activated cAMP Response Element Binding Protein Is Overexpressed in Human Mesotheliomas and Inhibits Apoptosis. American Journal of Pathology. 2009 Nov;175(5):2197-206.   PMCID: PMC 2774081
Timakhov RA, Tan YF, Rao M, Liu ZM, Altomare DA, Pei JM, Wiest DL, Favorova OO, Knepper JE, Testa JR. Recurrent Chromosomal Rearrangements Implicate Oncogenes Contributing to T-Cell Lymphomagenesis in Lck-MyrAkt2 Transgenic Mice. Genes Chromosomes & Cancer. 2009 Sep;48(9):786-94.   PMCID: PMC 2739734
Xu J, Testa JR. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC. The Journal of biological chemistry. 2009 Jul 31;284(31):20593-601.   PMCID: PMC2742824
Ji YB, Tulin AV. Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing. Nucleic acids research. 2009 Jun;37(11):3501-13.   PMCID: PMC2699505
Kotova E, Jarnik M, Tulin AV. Poly (ADP-Ribose) Polymerase 1 Is Required for Protein Localization to Cajal Body - art. no. e1000387. Plos Genetics. 2009 Feb;5(2):387.   PMCID: PMC2637609
Sekiya T, Muthurajan UM, Luger K, Tulin AV, Zaret KS. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev. 2009 Apr;23(7):804-9.   PMCID: PMC2666343
Boorjian SA, Uzzo RG. The evolving management of small renal masses. Current oncology reports. 2009 May;11(3):211-7.   PMCID: PMC2864077
Chen DY, Uzzo RG. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw. 2009 Jun;7(6):635-43.   PMCID: PMC2759676
Jimbo M, Myers RE, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Annals of Family Medicine. 2009 Jan;7(1):11-6.   PMCID: PMC2625842
Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients. Expert Review of Molecular Diagnostics. 2009 Nov;9(8):777-85.   PMCID: PMC2810399
Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li YY, Weinberg DS. Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer. JAMA-Journal of the American Medical Association. 2009 Feb;301(7):745-52.   PMCID: PMC 2756012
Paul E, Cronan R, Weston PJ, Boekelheide K, Sedivy JM, Lee SY, Wiest DL, Resnick MB, Klysik JE. Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death. Mammalian Genome. 2009 Feb;20(2):92-108.   PMCID: PMC2667228
Wiest DL. Identification of the last cog in a ligand-independent signaling machine?. J Immunol. 2009 May;182(9):5163-4.   PMCID: No NIH - Comment
Xu M, Sharma A, Hossain MZ, Wiest DL, Sen JM. Sustained Expression of Pre-TCR Induced beta-Catenin in Post-beta-Selection Thymocytes Blocks T Cell Development. Journal of Immunology. 2009 Jan;182(2):759-65.   PMCID: PMC 2701226
Xu M, Sharma A, Wiest DL, Sen JM. Pre-TCR-Induced beta-Catenin Facilitates Traversal through beta-Selection. Journal of Immunology. 2009 Jan;182(2):751-8.   PMCID: PMC 2657338
Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB, Shibata S, Romanus D, Niland J, Schrag D. Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer. Journal of Surgical Oncology. 2009 Dec;100(7):525-8.   PMCID: not NIH funded
Putt M, Long JA, Montagnet C, Silber JH, Chang VW, Liao KJ, Schwartz JS, Pollack CE, Wong YN, Armstrong K. Racial Differences in the Impact of Comorbidities on Survival Among Elderly Men With Prostate Cancer. Medical Care Research and Review. 2009 Aug;66(4):409-35.   PMCID: PMC2780425
Romanus D, Weiser MR, Skibber JM, Ter Veer A, Niland JC, Wilson JL, Rajput A, Wong YN, Benson AB, Shibata S, Schrag D. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: An NCCN Institutional Analysis. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):895-904.   PMCID: not NIH funded
Temple LK, Romanus D, Niland J, Veer AT, Weiser MR, Skibber J, Wilson J, Rajput A, Benson A, Wong YN, Schrag D. Factors Associated With Sphincter-Preserving Surgery for Rectal Cancer at National Comprehensive Cancer Network Centers. Annals of Surgery. 2009 Aug;250(2):260-7.
Fazlieva R, Spittle CS, Morrissey D, Hayashi H, Yan H, Matsumoto Y. Proofreading exonuclease activity of human DNA polymerase delta and its effects on lesion-bypass DNA synthesis. Nucleic acids research. 2009 May;37(9):2854-66.   PMCID: PMC2685094
Beeharry N, Yen TJ. p53-dependent apoptosis in response to spindle damage is linked to loss of Bub1. Cancer Biol Ther. 2009 Apr;8(7):645-7.
Huang H, Yen TJ. BubR1 is an effector of multiple mitotic kinases that specifies kinetochore: microtubule attachments and checkpoint. Cell cycle (Georgetown, Tex). 2009 Apr 15;8(8):1164-7.
Kong XD, Ball AR, Sonoda E, Feng J, Takeda S, Fukagawa T, Yen TJ, Yokomori K. Cohesin Associates with Spindle Poles in a Mitosis-specific Manner and Functions in Spindle Assembly in Vertebrate Cells. Molecular Biology of the Cell. 2009 Mar;20(5):1289-301.   PMCID: PMC2649254
Nozawa K, Ikeda K, Satoh M, Reeves WH, Stewart CM, Li YC, Yen TJ, Rios RM, Takamori K, Ogawa H, Sekigawa I, Takasaki Y, Chan EK. Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome. Frontiers in Bioscience. 2009 Jan;14:3733-9.   PMCID: PMCID: PMC2864436
Wan XH, O'Quinn RP, Pierce HL, Joglekar AP, Gall WE, DeLuca JG, Carroll CW, Liu ST, Yen TJ, McEwen BF, Stukenberg T, Desai A, Salmon ED. Protein Architecture of the Human Kinetochore Microtubule Attachment Site. Cell. 2009 May;137(4):672-84.   PMCID: PMC 2699050
Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A, Wang C, Hernandez-Cuebas L, Seeholzer LF, Nicolas E, Hensley H, Jordan VC, Walker CL, Henske EP. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proceedings of the National Academy of Sciences of the United States of America. 2009 Feb;106(8):2635-40.   PMCID: PMC 2637277
Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G. Intraepithelial T Cells and Tumor Proliferation. Cancer. 2009 Jul;115(13):2891-902.   PMCID: PMC2754811
Aghajanian C, Blessing JA, Darcy KM, Reid G, DeGeest K, Rubin SC, Mannel RS, Rotmensch J, Schilder RJ, Riordan W. A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 2009 Nov;115(2):215-20.
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors. American Journal of Pathology. 2009 Dec;175(6):2657-67.   PMCID: PMC2789618
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L. Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference. Cancer . 2009 Jan;115(10):2247-51.   PMCID: PMC2892290
Banumathy G, Somaiah N, Zhang RG, Tang Y, Hoffmann J, Andrake M, Ceulemans H, Schultz D, Marmorstein R, Adams PD. Human UBN1 Is an Ortholog of Yeast Hpc2p and Has an Essential Role in the HIRA/ASF1a Chromatin-Remodeling Pathway in Senescent Cells. Molecular and Cellular Biology. 2009 Feb;29(3):758-70.   PMCID: PMC2630694
Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV. Development and Characterization of Reference Materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 Genetic Testing. Journal of Molecular Diagnostics. 2009 Nov;11(6):553-61.   PMCID: PMC2765754
Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan V. Early breast cancer. Lancet. 2009 Jan;373(9673):1463-79.
Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, Lancaster JM. Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome. Clin Cancer Res. 2009 Apr;15(7):2448-55.   PMCID: PMC 3050629
Blumberg BS, Faithorn L. Lessons learned from the NASA Astrobiology Institute. In: Salmons J, Wilson L, editors. Handbook of research on electronic collaboration and organizational synergy. Hershey: Information Science Reference; 2009. p. 741-56.
Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009 Mar 20;27(9):1419-25.   PMCID: PMC 2668552
Boorjian SA, Berglund RK, Maschino AC, Savage CJ, Herr HW. Fibrin Clot Inhibitor Medication and Efficacy of Bacillus Calmette-Guerin for Bladder Urothelial Cancer. Journal of Urology. 2009 Oct;182(4):1306-11.
Boorjian SA, Blute ML. Surgery for vena caval tumor extension in renal cancer. Current Opinion in Urology. 2009 Sep;19(5):473-7.
Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Blute ML. Radiation Therapy After Radical Prostatectomy: Impact on Metastasis and Survival. Journal of Urology. 2009 Dec;182(6):2708-14.
Boquoi A, Chen T, Enders GH. Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research. 2009 Sep;2(9):800-6.   PMCID: PMC2819381
Boquoi A, Jover R, Chen TN, Pennings M, Enders GH. Transgenic Expression of VEGF in Intestinal Epithelium Drives Mesenchymal Cell Interactions and Epithelial Neoplasia. Gastroenterology. 2009 Feb;136(2):596-606.   PMCID: PMC2824597
Bowen DJ, Miller SM. Communication in cancer prevention and control. J Health Commun. 2009 Jan;14 Suppl 1:3-4.   PMCID: Pmc2882622
Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Hlubocky F, Olopade OI, Daugherty CK. Learning of your parent's BRCA mutation during adolescence or early. Psycho Oncology. 2009 Jan;18(2):200-8.   PMCID: not NIH funded
Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes & Control. 2009 Jul;20(5):713-20.   PMCID: not NIH funded
Brauch H, Jordan VC. Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The 'personalised' approach?. European Journal of Cancer. 2009 Sep;45(13):2274-83.   PMCID: not NIH funded
Burtness B, Anadkat M, Basti S, Hughes M, Lacouture ME, McClure JS, Myskowski PL, Paul J, Perlis CS, Saltz L, Spencer S. NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. J Natl Compr Canc Netw. 2009 May;7 Suppl 1:S5-S21; quiz S22-4.
Buyyounouski MK. Surveillance for stage I seminoma: better the devil you know than the devil you don't?. Oncology (Williston Park). 2009 Aug;23(9):762, 764.   PMCID: Comment - no NIH
Cairns P. 5'-azacytidine expression arrays. Methods Mol Biol. 2009 Jan;507:165-74.
Camidge R, Gaspar L, Goss G, Kelly K, Ramalingam S, Reckamp K, Simon G, Tsao M, West HJ, Herbst R, Johnson D, Bunn P, Govindan R. Summary of Selected Presentations from the 8th Annual Targeted Therapy in Lung Cancer Symposium. J Thorac Oncol. 2009 Jul;4(7):930-5.   PMCID: not NIH funded
Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta. 2009 Oct;1793(10):1540-70.   PMCID: PMC2744640
Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP. The significance of GATA3 expression in breast cancer: a 10-year follow-up study. Human Pathology. 2009 Apr;40(4):489-95.
Cohen RB, Jones SF, Aggarwal C, von Mehren M, Cheng J, Spigel DR, Greco FA, Mariani M, Rocchetti M, Ceruti R, Comis S, Laffranchi B, Moll J, Burris HA. A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors. Clinical Cancer Research. 2009 Nov;15(21):6694-701.
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National cancer Database report on cancer of the head and neck: 10-year update. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2009 Jun;31(6):748-58.
Cooper KF, Mallory MJ, Guacci V, Lowe K, Strich R. Pds1p Is Required for Meiotic Recombination and Prophase I Progression in Saccharomyces cerevisiae. Genetics. 2009 Jan;181(1):65-79.   PMCID: PMC2621190
Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R. CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer. Stem Cells. 2009 Dec;27(12):2875-83.   PMCID: not NIH funded
de Camargo VP, van de Rijn M, de Alava E, Madoz-Gurpide J, Pilotti S, von Mehren M, Pedeutour F, Maki RG, Rutkowski P, Thomas DM. Other Targetable Sarcomas. Seminars in Oncology. 2009 Aug;36(4):358-71.   PMCID: not NIH funded
DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, ACOSOG Intergrp Adjuvant GIST Stud. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar;373(9669):1097-104.   PMCID: PMC2915459
Demetri GD, Chawla SP, von Mehren M, Ritch P, Baker LH, Blay JY, Hande KR, Keohan ML, Samuels BL, Schuetze S, Lebedinsky C, Elsayed YA, Izquierdo MA, Gomez J, Park YC, Le Cesne A. Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules. Journal of Clinical Oncology. 2009 Sep;27(25):4188-96.   PMCID: not NIH funded
Demetri GD, Wang YF, Wehrle E, Racine A, Nikolova Z, Blanke CD, Joensuu H, von Mehren M. Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2009 Jul;27(19):3141-7.   PMCID: not NIH funded
Devarajan K, Ebrahimi N. Testing for Covariate Effect in the Cox Proportional Hazards Regression Model. Commun Stat Theory Methods. 2009 Jan;38(14):2333-47.   PMCID: PMC2802211
Diefenbach M, Turner G, Carpenter KM, Sheldon LK, Mustian KM, Gerend MA, Rini C, Von Wagner C, Gritz ER, McQueen A, Prayor-Patterson HM, Miller SM. Cancer and patient-physician communication. Journal of Health Communication. 2009 Jan;14(Suppl1):57-65.   PMCID: PMC2791918
Dominguez-Brauer C, Chen YJ, Brauer PM, Pimkina J, Raychaudhuri P. ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4. Embo Reports. 2009 Sep;10(9):1036-42.   PMCID: PMC2570060
Dong XY, Guo P, Boyd J, Sun XD, Li QN, Zhou W, Dong JT. Implication of snoRNA U50 in human breast cancer. Journal of Genetics and Genomics. 2009 Aug;36(8):447-54.   PMCID: PMCID: PMC2854654
Duan ZF, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemotherapy and Pharmacology. 2009 Mar;63(4):681-9.   PMCID: PMC2875930
Dupart JJ, Trent JC, Lee HY, Hess KR, Godwin AK, Taguchi T, Zhang W. Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro - art. no. 99. Molecular Cancer. 2009 Nov;8:99.   PMCID: PMC2780392
Dutcher JP, de Souza P, McDermott D, Figlin RA, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Hudes G. Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Medical Oncology . 2009 Jan;26(2):202-9.   PMCID: not NIH funded
Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, Smith MR. Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31. Journal of Clinical Oncology. 2009 Jan;27(1):92-9.   PMCID: PMC2645096
Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M. Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665. Journal of Surgical Oncology. 2009 Jan;99(1):42-7.   PMCID: PMC2606912
Enders GH. Wnt therapy for bone loss: golden goose or Trojan horse?. J Clin Invest. 2009 Apr;119(4):758-60.   PMCID: PMC2662580
Faller BA, Burtness B. Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy. Cancer Management and Research. 2009 Aug;:107-16.   PMCID: PMC2747340
Figlin RA, de Souza P, McDermott D, Dutcher JP, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Boni J, Hudes G. Analysis of PTEN and HIF-1 alpha and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-alpha. Cancer. 2009 Aug;115(16):3651-60.   PMCID: not NIH funded
Fourkal E, Fan J, Veltchev I. Absolute dose reconstruction in proton therapy using PET imaging modality: feasibility study. Phys Med Biol. 2009 Jun 07;54(11):N217-28.
Gadue P, Gouon-Evans V, Cheng X, Wandzioch E, Zaret KS, Grompe M, Streeter PR, Keller GM. Generation of Monoclonal Antibodies Specific for Cell Surface Molecules Expressed on Early Mouse Endoderm. Stem Cells. 2009 Jan;27(9):2103-13.   PMCID: PMC2890285
Garrido F, Alfonso C, Taylor JC, Markham GD, Pajares MA. Subunit association as the stabilizing determinant for archaeal methionine adenosyltransferases. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2009 Jul;1794(7):1082-90.   PMCID: PMC2704562
Geller G, Micco E, Silver RJ, Kolodner K, Bernhardt BA. The Role and Impact of Personal Faith and Religion Among Genetic Service Providers. American Journal of Medical Genetics Part C-Seminars in Medical Genetics. 2009 Feb;151C(1):31-40.
Gerson LB, Tokar J, Chiorean M, Lo S, Decker GA, Cave D, Bouhaidar D, Mishkin D, Dye C, Haluszka O, Leighton JA, Zfass A, Semrad C. Complications Associated With Double Balloon Enteroscopy at Nine US Centers. Clinical Gastroenterology and Hepatology. 2009 Nov;7(11):1177-82.
Giri VN, Coups EJ, Ruth K, Goplerud J, Raysor S, Kim TY, Bagden L, Mastalski K, Zakrzewski D, Leimkuhler S, Watkins-Bruner D. Prostate cancer early detection program recruitment methods and show rates in men at high risk. J Urol. 2009 Nov;182(5):2212-7.   PMCID: PMC2760660
Goodgame B, Stinchcombe TE, Simon G, Wozniak A, Govindan R. Recent Advances in Lung Cancer: Summary of Presentations from the 45th Annual Meeting of the American Society of Clinical Oncology (2009). J Thorac Oncol. 2009 Oct;4(10):1293-300.   PMCID: not NIH funded
Gumbs AA, Fowler D, Milone L, Evanko JC, Ude AO, Stevens P, Bessler M. Transvaginal Natural Orifice Translumenal Endoscopic Surgery Cholecystectomy Early Evolution of the Technique. Annals of Surgery. 2009 Jun;249(6):908-12.
Gumbs AA, Milone L, Geha R, Delacroix J, Chabot JA. Laparoscopic Radical Cholecystectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2009 Aug;19(4):519-20.   PMCID: not NIH funded
Gumbs AA, Zain J, O'Connor OA. Importance of Early Splenectomy in Patients with Hepatosplenic T-Cell Lymphoma and Severe Thrombocytopenia. Annals of Surgical Oncology. 2009 Jul;16(7):2014-7.
Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon BJ, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB. Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B. Pediatrics. 2009 Nov;124(5):E1007-E1013.   PMCID: not NIH funded
Han Z, Alves C, Gudima S, Taylor J. Intracellular localization of hepatitis delta virus proteins in the presence and absence of viral RNA accumulation. J Virol. 2009 Jul;83(13):6457-63.   PMCID: PMC2698582
Hartman TR, Liu DY, Zilfou JT, Robb V, Morrison T, Watnick T, Henske EP. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Human molecular genetics. 2009 Jan;18(1):151-63.   PMCID: PMC2644647
Hay J, Coups EJ, Ford J, DiBonaventura M. Exposure to mass media health information, skin cancer beliefs, and sun protection behaviors in a United States probability sample. Journal of the American Academy of Dermatology. 2009 Nov;61(5):783-92.   PMCID: PMC2854488
Held-Warmkessel J. Syndrome of inappropriate antidiurectic hormone (SIADH). In: Chernecky CC, Murphy-Ende K, editors. Acute care oncology nursing. St. Louis, Mo.: Saunders/Elsevier; 2009. p. 534-44.
Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT. Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management. Journal of Allergy and Clinical Immunology. 2009 Jun;123(6):1262-7.
Hoffman JP, Stitzenberg KB. Preoperative versus postoperative adjuvant therapy for adenocarcinoma of the pancreas. Adv Surg. 2009 Jan;43:189-98.
Hopper-Borge E, Xu X, Shen T, Shi Z, Chen ZS, Kruh GD. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. Cancer Res. 2009 Jan;69(1):178-84.   PMCID: PMC2745904
Hudes GR. Targeting mTOR in renal cell carcinoma. Cancer. 2009 Apr 28;115(S10):2313-20.   PMCID: not NIH funded
Hudes GR, Berkenblit A, Feingold J, Atkins MB, Rini BI, Dutcher J. Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma. Semin Oncol. 2009 Dec;36 Suppl 3:S26-36.
Hudson SV, Hahn KA, Ohman-Strickland P, Cunningham RS, Miller SM, Crabtree BF. Breast, Colorectal and Prostate Cancer Screening for Cancer Survivors and Non-Cancer Patients in Community Practices. Journal of General Internal Medicine. 2009 Nov;24:487-90.   PMCID: PMC2763158
Jordan VC. A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention. Cancer Research. 2009 Feb;69(4):1243-54.
Jordan VC, Lewis-Wambi JS, Patel RR, Kim H, Ariazi EA. New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast. 2009 Oct;18 Suppl 3:S10-7.   PMCID: PMC2867601
Kanetsky PA, Mitra N, Vardhanabhuti S, Li MY, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J, Albano A, Chen C, Starr JR, Rader DJ, Godwin AK, Reilly MP, Hakonarson H, Schwartz SM, Nathanson KL. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature genetics. 2009 Jul;41(7):811-5.   PMCID: PMC2865677
Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu WW. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proceedings of the National Academy of Sciences of the United States of America. 2009 Jun;106(24):9761-6.   PMCID: PMC2700980
Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, Blakely LJ, Eisenberg PD, Langer CJ, Blumenschein G, Johnson FM, Green S, Gualberto A. Phase II Study of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2009 May;27(15):2516-22.   PMCID: not NIH funded
Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin DH, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A. Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin. Journal of Thoracic Oncology. 2009 Nov;4(11):1397-403.   PMCID: PMC2941876
Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Sanjeeviah RC, Vijayakumar M, Kumar KV, Montgomery E, Kumar RV, Pandey A. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biology & Therapy. 2009 Jan;8(1):36-46.   PMCID: not NIH funded
Kell MR, Morrow M. Surgical Aspects of Inflammatory Breast Cancer. Breast Dis. 2009 Sep 03;22:67-73.
Kim HJ, Barsevick AM, Tulman L. Predictors of the Intensity of Symptoms in a Cluster in Patients With Breast Cancer. Journal of Nursing Scholarship. 2009 Jan;41(2):158-65.   PMCID: PMC2884278
Kirkwood JM, Lee S, Moschos S, Albertini MR, Michalak JC, Sander C, Whiteside T, Butterfield LH, Weiner L. Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-alpha 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696. Clinical Cancer Research. 2009 Feb;15(4):1443-51.   PMCID: PMC2769898
Kloth DD. New pharmacologic findings for the treatment of PONV and PDNV. Am J Health Syst Pharm. 2009 Jan;66(1 Suppl 1):S11-8.
Koch KM, Reddy NJ, Cohen RB, Lewis NL, Whitehead B, Mackay K, Stead A, Beelen AP, Lewis LD. Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients. Journal of Clinical Oncology. 2009 Mar;27(8):1191-6.   PMCID: not NIH funded
Konski AA, Winter K, Cole BF, Ang KK, Fu KK. Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma. Head & neck. 2009 Feb;31(2):207-12.
Konski A, James J, Hartsell W, Leibenhaut MH, Janjan N, Curran W, Roach M, Watkins-Bruner D. Economic Analysis of Radiation Therapy Oncology Group 97-14 Multiple Versus Single Fraction Radiation Treatment of Patients With Bone Metastases. American Journal of Clinical Oncology-Cancer Clinical Trials. 2009 Aug;32(4):423-8.   PMCID: PMC2628953
Kotova E, Coleman T, Serebriiskii I. Two-hybrid dual bait system. Curr Protoc Mol Biol. 2009 Apr;Chapter 20:Unit 20 7.
Lai JS, Butt Z, Wagner L, Sweet JJ, Beaumont JL, Vardy J, Jacobsen PB, Shapiro PJ, Jacobs SR, Cella D. Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage. 2009 Jun;37(6):982-95.   PMCID: PMC2737504
Lake RJ, Grimm LM, Veraksa A, Banos A, Artavanis-Tsakonas S. In Vivo Analysis of the Notch Receptor S1 Cleavage. PLoS One. 2009 Aug;4(8 ):e6728.   PMCID: PMC2726433
Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Thomas CR, Blackstock AW. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009 Jan;64(2):226-31.   PMCID: NIHMS117386
Larkin JD, Markham GD, Milkevitch M, Brooks BR, Bock CW. Computational Investigation of the Oxidative Deboronation of Boroglycine, H2N-CH2-B(OH)(2), Using H2O and H2O2. Journal of Physical Chemistry A. 2009 Oct;113(41):11028-34.
Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH-RISK PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2009 Jun;74(2):383-7.   PMCID: PMC2905150
Leong S, Cohen RB, Gustafson DL, Langer CJ, Camidge DR, Padavic K, Gore L, Smith M, Chow LQ, von Mehren M, O'Bryant C, Hariharan S, Diab S, Fox NL, Miceli R, Eckhardt SG. Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study. Journal of Clinical Oncology. 2009 Sep;27(26):4413-21.   PMCID: not NIH funded
Lessin SR. Alibert Lymphoma: Renaming Mycosis Fungoides. Arch Dermatol. 2009 Feb;145(2):209-10.   PMCID: not NIH funded
Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A Small Molecule Inhibitor of Inducible Heat Shock Protein 70. Molecular Cell. 2009 Oct;36(1):15-27.   PMCID: PMC2771108
Levy MH, Back A, Benedetti C, Billings JA, Block S, Boston B, Bruera E, Dy S, Eberle C, Foley KM, Karver SB, Knight SJ, Misra S, Ritchie CS, Spiegel D, Sutton L, Urba S, Von Roenn JH, Weinstein SM. NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw. 2009 Apr;7(4):436-73.   PMCID: not NIH funded
Lewis-Wambi JS, Jordan VC. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?. Breast Cancer Res. 2009 Jan;11(3):206.   PMCID: PMC2716493
Lewis-Wambi JS, Swaby R, Kim H, Jordan VC. Potential of L-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 2009 Mar;114(1-2):33-9.   PMCID: PMC28689080
Li JQ, Callaway DJ, Bu ZM. Ezrin Induces Long-Range Interdomain Allostery in the Scaffolding Protein NHERF1. Journal of Molecular Biology. 2009 Sep;392(1):166-80.
Lilenbaum R, Villaflor VM, Langer C, O'Byrne K, O'Brien M, Ross HJ, Socinski M, Oldham FB, Sandilac L, Singer JW, Bonomi P. Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2 Prognostic Factors and Treatment Selection Based on Two Large Randomized Clinical Trials. Journal of Thoracic Oncology. 2009 Jan;4(7):869-74.   PMCID: not NIH funded
Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G. Photodynamic Molecular Beacon Triggered by Fibroblast Activation Protein on Cancer-Associated Fibroblasts for Diagnosis and Treatment of Epithelial Cancers. Journal of medicinal chemistry. 2009 Jan;52(2):358-68.   PMCID: PMC2773291
Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK. Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management. Molecular Oncology. 2009 Apr;3(2):97-137.   PMCID: PMC2778287
Mackenzie A, Patrick-Miller L, Bradbury AR. Controversies in communication of genetic risk for hereditary breast cancer. Breast J. 2009 Sep;15 Suppl 1:S25-32.   PMCID: not NIH funded
Manion FJ, Robbins RJ, Weems WA, Crowley RS. Security and privacy requirements for a multi-institutional cancer research data grid: an interview-based study. BMC Med Inform Decis Mak. 2009 Jan;9:31.   PMCID: PMC2709611
Manne S. Commentary: Adopting to a broad perspective on posttraumatic stress disorders, childhood medical illness and injury. Journal of Pediatric Psychology. 2009 Jan;34(1):22-6.   PMCID: not NIH funded
Manne SL. Review of Helping couples cope with women's cancers: An evidence-based approach for practitioners. Psycho Oncology. 2009 Jan;18(8):903-4.
Manne S, Ostroff J, Fox K, Grana G, Winkel G. Cognitive and social processes predicting partner psychological adaptation to early stage breast cancer. British Journal of Health Psychology. 2009 Feb;14(1):49-68.   PMCID: PMC2684810
Manne SL. Helping Couples Cope with Women's Cancers: An Evidence-Based Approach for Practitioners. Psycho-Oncology. 2009 Aug;18(8):903-4.
Manne SL, Coups EJ, Markowitz A, Meropol NJ, Haller D, Jacobsen PB, Jandorf L, Peterson SK, Lesko S, Pilipshen S, Winkel G. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med. 2009 Apr;37(2):207-17.   PMCID: PMC2707254
Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK. Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer. Health education research. 2009 Oct;24(5):897-908.   PMCID: PMC2738960
Markham GD, Pajares MA. Structure-function relationships in methionine adenosyltransferases. Cell Mol Life Sci. 2009 Feb;66(4):636-48.   PMCID: PMC2643306
Markham GD, Takusagawa F, Dijulio AM, Bock CW. An investigation of the catalytic mechanism of S-adenosylmethionine synthetase by QM/MM calculations. Arch Biochem Biophys. 2009 Dec;492(1-2):82-92.   PMCID: PMC2788016
Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE. Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol. 2009 Sep;83(17):8396-408.   PMCID: PMC2738144
Mason WS, Xu CX, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR. The Amount of Hepatocyte Turnover That Occurred during Resolution of Transient Hepadnavirus Infections Was Lower When Virus Replication Was Inhibited with Entecavir. Journal of Virology. 2009 Feb;83(4):1778-89.   PMCID: PMC2643773
Maximov PY, Lewis-Wambi JS, Jordan VC. The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis. Current Signal Transduction Therapy. 2009 May;4(2):88-102.   PMCID: PMC2757321
McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Kaaks R, Rinaldi S, Helzlsouer KJ. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. International journal of cancer. 2009 Aug;125(3):674-9.   PMCID: PMC2706295
Meehan KB, Levy KN, Reynoso JS, Hill LL, Clarkin JF. Measuring reflective function with a multidimensional rating scale: Comparison with scoring reflective function on the AAI. J Am Psychoanal Assoc. 2009 Feb;57(1):208-13.
Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs timeto neurologic progression in non-small-cell lung cancer patients with brain metases: results of a phase III trial. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1069-76.   PMCID: not NIH funded
Melnikov A, Scholtens D, Godwin A, Levenson V. Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma. Journal of Molecular Diagnostics. 2009 Jan;11(1):60-5.   PMCID: PMC2607567
Meropol NJ. The significance of circulating tumor cells as prognostic markers for colon cancer. Clin Adv Hematol Oncol. 2009 Apr;7(4):247-8.   PMCID: not NIH funded
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10;27(23):3868-74.
Michalski JM, Roach M, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR. ACR Appropriateness Criteria (R) on External Beam Radiation Therapy Treatment Planning for Clinically Localed Prostate Cancer Expert Panel on Radiation Oncology-Prostate. International Journal of Radiation Oncology Biology Physics. 2009 Jul;74(3):667-72.
Miller KA, Yeager N, Baker K, Liao XH, Refetoff S, Di Cristofano A. Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res. 2009 Apr 15;69(8):3689-94.   PMCID: PMC2669852
Miller SM, Bowen DJ, Croyle RT, Rowland JH. Overview, current status, and future directions. [References]. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH, editors. Handbook of cancer control and behavioral science: A resource for researchers, practitioners, and policymakers. Washington, DC: American Psychological Association; 2009. p. 5-22.
Miller SM, Bowen DJ, Croyle RT, Rowland JH. Handbook of cancer control and behavioral science: A resource for researchers, practitioners, and policymakers. In: Handbook of cancer control and behavioral science: A resource for researchers, practitioners, and policymakers. Washington, DC, US: American Psychological Association; 2009. p. 652.
Moore R, Cai KQ, Escudero DO, Xu XX. Cell Adhesive Affinity Does Not Dictate Primitive Endoderm Segregation and Positioning During Murine Embryoid Body Formation. Genesis. 2009 Sep;47(9):579-89.   PMCID: PMC2755612
Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A. Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Oct;20(10):1163-8.   PMCID: Case report/not NIH funded
Morgan PB, Sopka DM, Kathpal M, Haynes JC, Lally BE, Li L. First author research productivity of United States radiation oncology residents: 2002-2007. Int J Radiat Oncol Biol Phys. 2009 Aug;74(5):1567-72.
Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Wasserman T, Bruner DW. Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. Journal of Clinical Oncology. 2009 Dec;27(34):5816-22.   PMCID: PMC2793002
Nakajima PB, Kiefer K, Price A, Bosma GC, Bosma MJ. Two distinct populations of H chain-edited B cells show differential surrogate L chain dependence. J Immunol. 2009 Mar 15;182(6):3583-96.   PMCID: PMC2775077
Norton TR, Lazev AB, Schnoll RA, Miller SM. The impact of email recruitment on our understanding of college smoking. Addictive Behaviors. 2009 Jan;34(6-7):531-5.   PMCID: PMC2802216
O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT. Familial Risk for Common Diseases in Primary Care The Family Healthware (TM) Impact Trial. American Journal of Preventive Medicine. 2009 Jan;36(6):506-14.   PMCID: not NIH funded
Oostendorp RL, Loftiss J, Goel S, Smith DA, Dar MM, Witteveen PO, Cohen RB, Lewis LD, Kurian S, Patnaik A, Rosing H, Beijnen JH, Voest EE, Burris H, Schellens JH. Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 2009 Mar;47(3):195-206.   PMCID: not NIH funded
Palamar M, Thangappan A, Shields CL, Ehya H, Shields JA. Necrotic Choroidal Melanoma With Scleritis and Choroidal Effusion. Cornea. 2009 Apr;28(3):354-6.   PMCID: not NIH funded
Paya A, Alenda C, Perez-Carbonell L, Rojas E, Soto JL, Guillen C, Castillejo A, Barbera VM, Carrato A, Castells A, Llor X, Andreu M, Koh J, Enders GH, Benlloch S, Jover R. Utility of p16 Immunohistochemistry for the Identification of Lynch Syndrome. Clinical Cancer Research. 2009 May;15(9):3156-62.   PMCID: PMC2825754
Peng J, Sengupta S, Jordan VC. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anticancer Agents Med Chem. 2009 Jun;9(5):481-99.
Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J. Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment. Journal of Clinical Oncology. 2009 Nov;27(33):5660-9.   PMCID: not NIH funded
Pimkina J, Humbey O, Zilfou JT, Jarnik M, Murphy ME. ARF Induces Autophagy by Virtue of Interaction with Bcl-xl. Journal of Biological Chemistry. 2009 Jan;284(5):2803-10.   PMCID: PMC2631963
Pimkina J, Murphy ME. ARF, autophagy and tumor suppression. Autophagy. 2009 Apr;5(3):397-9.   PMCID: PMC2667648
Pimkin M, Markham GD. Inosine 5'-monophosphate dehydrogenase. Adv Enzymol Relat Areas Mol Biol. 2009 Jan;76:1-53.
Pimkin M, Pimkina J, Markham GD. A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis. Journal of Biological Chemistry. 2009 Mar;284(12):7957-66.   PMCID: PMC2658089
Qian Y, Tchuvatkina O, Spidlen J, Wilkinson P, Gasparetto M, Jones AR, Manion FJ, Scheuermann RH, Sekaly RP, Brinkman RR. FuGEFlow: data model and markup language for flow cytometry. BMC Bioinformatics. 2009 Jan;10:184.   PMCID: PMC2711079
Quillin JM, Tracy K, Ancker JS, Mustian KM, Ellington L, Viswanath V, Miller SM. Health care system approaches for cancer patient communication. Journal of Health Communication. 2009 Jan;14(Suppl1):85-94.   PMCID: PMC2805414
Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 2009 Mar;112(3):583-9.   PMCID: PMC2858218
Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM. Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial. Journal of the National Cancer Institute. 2009 Feb;101(4):228-36.   PMCID: PMC2734115
Reitz AB, Smith GR, Tounge BA, Reynolds CH. Hit triage using efficiency indices after screening of compound libraries in drug discovery. Curr Top Med Chem. 2009 Jan;9(18):1718-24.
Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP. Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 2009 Sep;27(27):4462-8.   PMCID: not NIH funded
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. Journal of Clinical Oncology. 2009 Apr;27(10):1572-8.   PMCID: not NIH funded
Satia JA, Tseng M, Galanko JA, Martin C, Sandler RS. Dietary Patterns and Colon Cancer Risk in Whites and African Americans in the North Carolina Colon Cancer Study. Nutrition and Cancer-an International Journal. 2009 Jan;61(2):179-93.   PMCID: NIHMS 176444
Schilder RJ, Sill MW, Lee YC, Mannel R. A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2009 Jul;19(5):929-33.   PMCID: PMC2722934
Schmitt MW, Matsumoto Y, Loeb LA. High fidelity and lesion bypass capability of human DNA polymerase delta. Biochimie. 2009 Sep;91(9):1163-72.   PMCID: PMC 2774493
Seiden MV. Progress in gynecologic cancer. Semin Oncol. 2009 Apr;36(2):90.   PMCID: No NIH
Sharkey RM, Karacay H, Johnson CR, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenbero DM. Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma. Journal of Nuclear Medicine. 2009 Mar;50(3):444-53.
Simunovic M, Rempel E, Theriault ME, Baxter NN, Virnig BA, Meropol NJ, Levine MN. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Canadian Journal of Surgery. 2009 Aug;52(4):E79-E86.   PMCID: PMC 2724831
Singh LR, Dar TA, Ahmad F. Living with urea stress. J Biosci. 2009 Jun;34(2):321-31.
Singh LR, Dar TA, Rahman S, Jamal S, Ahmad F. Glycine betaine may have opposite effects on protein stability at high and low pH values. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2009 Jun;1794(6):929-35.   PMCID: No NIH
Slingluff CL, Petroni GR, Olson WC, Smolkin ME, Ross MI, Haas NB, Grosh WW, Boisvert ME, Kirkwood JM, Chianese-Bullock KA. Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8(+) and CD4(+) T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial. Clinical Cancer Research. 2009 Nov;15(22):7036-44.   PMCID: PMC 2778314
Somaiah N, Simon GR. Molecular Targeted Therapy in Non-small Cell Lung Cancer An Overview of Available Agents. Journal of Thoracic Oncology. 2009 Nov;4(11):S1046-S1056.
Somaiah N, von Mehren M. New therapeutic approaches for advanced gastrointestinal stromal tumors. Hematol Oncol Clin North Am. 2009 Feb;23(1):139-50.   PMCID: PMC2861350
Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AR, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi QL, Shinozaki G, Singh JA, Yang P, Zwinderman AH. The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-Reported Quality-of-Life Outcomes. Twin Research and Human Genetics. 2009 Jun;12(3):301-11.   PMCID: PMC 2824176
Sprehn GC, Chambers JE, Saykin AJ, Konski A, Johnstone PA. Decreased Cancer Survival in Individuals Separated at Time of Diagnosis Critical Period for Cancer Pathophysiology?. Cancer. 2009 Nov;115(21):5108-16.   PMCID: PMC 2767449
Stefanek ME, Andrykowski MA, Lerman C, Manne S, Glanz K, Aacr Behav Sci Task Force; AACR Behav Sci Task Force. Behavioral Oncology and the War on Cancer: Partnering with Biomedicine. Cancer Research. 2009 Sep;69(18):7151-6.
Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM. Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines. Clinical Cancer Research. 2009 Apr;15(8):2808-17.   PMCID: PMC 2681251
Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer. Journal of the National Comprehensive Cancer Network. 2009 Feb;7(2):115-21.   PMCID: No NIH
Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, Shirakawa Y, Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. International Journal of Oncology. 2009 Feb;34(2):313-9.
Taylor JC, Bock CW, Takusagawa F, Markham GD. Discovery of Novel Types of Inhibitors of S-Adenosylmethionine Synthesis by Virtual Screening. Journal of medicinal chemistry. 2009 Oct;52(19):5967-73.   PMCID: PMC 2869451
Taylor JM. Chapter 3. Replication of the hepatitis delta virus RNA genome. Adv Virus Res. 2009 Jan;74:103-21.
Tian CQ, Markman M, Zaino R, Ozols RF, McGuire WP, Muggia FM, Rose PG, Spriggs D, Armstrong DK, Gynecologic Oncology Grp Study; Gynecologic Oncology Grp S. CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers A Gynecologic Oncology Group Study. Cancer. 2009 Apr;115(7):1395-403.   PMCID: PMC 2743569
Tseng M, Vierkant RA, Kushi LH, Vachon CM, Sellers TA. Dietary patterns and breast density in the Minnesota breast cancer family study. Cancer Causes & Control. 2009 Jan;19(5):481-9.
Tseng M, Giri V, Bruner DW, Giovannucci E. Prevalence and correlates of vitamin D status in African American men. BMC public health. 2009 Jan;9:191.   PMCID: PMC2708155
Tseng M, Giri V, Watkins-Bruner D, Giovannucci E. Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer. Cancer Causes & Control. 2009 Dec;20(10):1947-54.   PMCID: PMC 2895954
Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, Rom W, Sanda M, Sorbara L, Stass S, Wang W, Brenner DE. Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group. Journal of Proteome Research. 2009 Jan;8(1):113-7.   PMCID: PMC 2655764
Vijayakumar S, Dziegielewska B, Levin DS, Song W, Yin J, Yang A, Matsumoto Y, Bermudez VP, Hurwitz J, Tomkinson AE. Phosphorylation of Human DNA Ligase I Regulates Its Interaction with Replication Factor C and Its Participation in DNA Replication and DNA Repair. Molecular and Cellular Biology. 2009 Apr;29(8):2042-52.   PMCID: PMC 2663303
Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM. American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. Journal of Clinical Oncology. 2009 Jul;27(19):3235-58.   PMCID: PMC 2716943
von Mehren M, Watson JC. Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?. Oncology (Williston Park). 2009 Jan;23(1):65-6.   PMCID: PMC 2861343
Wandzioch E, Zaret KS. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science. 2009 Jun 26;324(5935):1707-10.   PMCID: PMC 2771431
Wang C, Miller SM. Psychological issues in genetic testing. [References]. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH, editors. Handbook of cancer control and behavioral science: A resource for researchers, practitioners, and policymakers. Washington, DC: American Psychological Association; 2009. p. 303-21.
Wang C, O'Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE, Ruffin MI, F HITr Grp. Comparison of risk perceptions and beliefs across common chronic diseases. Preventive Medicine. 2009 Feb;48(2):197-202.   PMCID: PMC 2720609
Weaver C. Caring for a patient after mastectomy. Nursing. 2009 May;39(5):44-8.   PMCID: not NIH funded
Williams SJ, Cvetkovic D, Hamilton TC. Vitamin A metabolism is impaired in human ovarian cancer. Gynecologic Oncology. 2009 Mar;112(3):637-45.   PMCID: PMC 2737361
Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE. 2009 Jan;4(4):e5311.   PMCID: PMC2668797
Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes & Development. 2009 Dec;23(24):2824-38.   PMCID: PMC 2800090
Yang DH, Smith ER, Cai KQ, Xu XX. c-fos Elimination Compensates for disabled-2 Requirement in Mouse Extraembryonic Endoderm. Development. Developmental Dynamics. 2009 Mar;238(3):514-23.   PMCID: PMC 2743073
Young C. It takes a village to raise the world. Pa Nurse. 2009 Sep;64(3):10-2.   PMCID: not NIH funded
Yu EY, Wilding G, Posadas E, Gross M, Culine S, Massard C, Morris MJ, Hudes G, Calabro F, Cheng ST, Trudel GC, Paliwal P, Sternberg CN. Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 2009 Dec;15(23):7421-8.   PMCID: PMC 3394097
Zagurovskaya M, Shareef MM, Das A, Reeves A, Gupta S, Sudol M, Bedford MT, Prichard J, Mohiuddin M, Ahmed MM. EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells. Oncogene. 2009 Feb;28(8):1121-31.
Zaret KS. Using small molecules to great effect in stem cell differentiation. Cell Stem Cell. 2009 May 08;4(5):373-4.   PMCID: No NIH - Comment
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Prognostic value of surviving in locally advanced prostate cancer: study based on RTOG 8610. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1033-42.   PMCID: PMC 2678565
Zorn KK, Tian CQ, McGuire WP, Hoskins WJ, Markman M, Muggia FM, Rose PG, Ozols RF, Spriggs D, Armstrong DK. The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma A Gynecologic Oncology Group Study. Cancer. 2009 Mar;115(5):1028-35.   PMCID: PMC 2664510
Zubek VB, Konski A. Cost Effectiveness of Risk-Prediction Tools in Selecting Patients for Immediate Post-Prostatectomy Treatment. Molecular Diagnosis & Therapy. 2009 Jan;13(1):31-47.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2009


Last updated on Thursday, November 02, 2017